On March 20, 2024, SHHH developed the world’s first full-size developable drug loaded microspheres and obtained market approval from the National Food and Drug Administration (NMPA) of China. This microsphere is suitable for embolization treatment of malignant tumors of vascular rich parenchymal organs.
The world’s first full-size developable drug loaded microspheres are produced based on traditional methods, using patented iodine containing developing molecules (triiodobenzoic acid) combined with critical phase plane crosslinking technology to create the world’s only full-size developable drug loaded microspheres. At the same time, it solves the pain points of traditional microsphere particles that are too large to be embolized at the end and cannot be visualized after surgery.
SHHH is a globally innovative pan vascular intervention enterprise, specializing in cardiac intervention valves, coronary and peripheral blood vessels, tumor intervention, intervention robots, etc., with over 200 patents. The core product k-clip has successfully completed 250 surgeries in countries such as China, Europe, and America.